These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 8697997)
1. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma]. Wu J; Yu H; Shao Y Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997 [TBL] [Abstract][Full Text] [Related]
2. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
3. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
4. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
5. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L; Topolcan O Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252 [TBL] [Abstract][Full Text] [Related]
6. [Clinical value of carbohydrate antigen 50 and carbohydrate antigen 242 in the diagnosis of colorectal carcinoma]. Huang CW; Bai L Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1116-8. PubMed ID: 12480590 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer. Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of plasma fibrinogen level in patients with colorectal cancer]. Wang Q; Xie R; Zhang QY Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):544-6. PubMed ID: 16438853 [TBL] [Abstract][Full Text] [Related]
9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
10. [The diagnostic values of CA242 combining other tumor markers for lung cancer]. Zhang S; Ma Y; Yang X Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic value of CEA and GICA in colo-rectal tumors. A caseload contribution]. Lasagna B; Balbo G; De Paolis P; Sacchetti M Minerva Med; 1990 Nov; 81(11):769-71. PubMed ID: 2255411 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287 [TBL] [Abstract][Full Text] [Related]
13. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638 [TBL] [Abstract][Full Text] [Related]
14. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
15. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum]. Ial'chenko NA; Lagutin VD; Lavik NN; Musin II Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842 [TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma. Iemura K; Moriya Y Eur J Surg Oncol; 1993 Oct; 19(5):439-42. PubMed ID: 8405479 [TBL] [Abstract][Full Text] [Related]
17. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma. Forslund A; Engarås B; Lönnroth C; Lundholm K Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598 [TBL] [Abstract][Full Text] [Related]
18. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633 [TBL] [Abstract][Full Text] [Related]
19. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]